Security National Bank of So Dak’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $652K | Hold |
2,000
| – | – | 0.36% | 69 |
|
2025
Q1 | $540K | Hold |
2,000
| – | – | 0.31% | 72 |
|
2024
Q4 | $471K | Hold |
2,000
| – | – | 0.26% | 75 |
|
2024
Q3 | $550K | Hold |
2,000
| – | – | 0.31% | 69 |
|
2024
Q2 | $486K | Hold |
2,000
| – | – | 0.29% | 70 |
|
2024
Q1 | $299K | Hold |
2,000
| – | – | 0.18% | 86 |
|
2023
Q4 | $383K | Hold |
2,000
| – | – | 0.25% | 73 |
|
2023
Q3 | $354K | Hold |
2,000
| – | – | 0.26% | 77 |
|
2023
Q2 | $380K | Buy |
+2,000
| New | +$380K | 0.27% | 73 |
|
2022
Q4 | $475K | Hold |
2,000
| – | – | 0.34% | 66 |
|
2022
Q3 | $400K | Hold |
2,000
| – | – | 0.36% | 70 |
|
2022
Q2 | $292K | Hold |
2,000
| – | – | 0.24% | 79 |
|
2022
Q1 | $327K | Buy |
2,000
+500
| +33% | +$81.8K | 0.23% | 80 |
|
2021
Q4 | $254K | Hold |
1,500
| – | – | 0.17% | 90 |
|
2021
Q3 | $283K | Buy |
+1,500
| New | +$283K | 0.22% | 83 |
|
2021
Q2 | – | Sell |
-1,500
| Closed | -$212K | – | 98 |
|
2021
Q1 | $212K | Buy |
+1,500
| New | +$212K | 0.18% | 93 |
|
2020
Q4 | – | Sell |
-1,500
| Closed | -$218K | – | 89 |
|
2020
Q3 | $218K | Hold |
1,500
| – | – | 0.22% | 80 |
|
2020
Q2 | $222K | Buy |
+1,500
| New | +$222K | 0.25% | 72 |
|
2017
Q4 | – | Sell |
-2,100
| Closed | -$247K | – | 93 |
|
2017
Q3 | $247K | Buy |
+2,100
| New | +$247K | 0.28% | 81 |
|